Article in Metabolites, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Laura E WrightCollege of Medicine, Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-9568-4561
Jennifer B FryeDepartment of Medicine and School of Nutritional Sciences and Wellness, The University of Arizona, Tucson, AZ 85724, USA.
Andrew G KunihiroDepartment of Medicine and School of Nutritional Sciences and Wellness, The University of Arizona, Tucson, AZ 85724, USA.ORCID 0000-0002-7940-4889
Barbara N TimmermannDepartment of Medicinal Chemistry, The University of Kansas, Lawrence, KS 66045, USA.
Janet L FunkDepartment of Medicine and School of Nutritional Sciences and Wellness, The University of Arizona, Tucson, AZ 85724, USA.
Funding
Pharmacokinetics &pharmacodynamics of anti-inflammatory botanicalsP50AT000474 · NCCIH · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2000 to 2004
$6.8M
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone MetastasisR01CA174926 · NCI · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2014 to 2018
$1.6M
Identification of Natural Product Inhibitors of Breast Cancer Bone MetastasisR21AT005145 · NCCIH · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2010 to 2012
$523k
Efficacy of Turmeric Extract in Prevention of Post-menopausal OsteoporosisR21AT003614 · NCCIH · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2006 to 2009
$477k
Mechanistic Determinants of Dietary Polyphenol Bioactivity in BoneR21AR078424 · NIAMS · UNIVERSITY OF ARIZONA · PI FUNK, JANET L · 2021 to 2022
$383k
Ginger Extracts in the Prevention of Metabolic Bone DiseaseF31AT004875 · NCCIH · UNIVERSITY OF ARIZONA · PI WRIGHT, LAURA ELIZABETH · 2008 to 2011
$148k
Bone-specific deglucuronidation of turmeric-derived curcuminoids for the treatment of osteolytic diseaseF31AT009938 · NCCIH · UNIVERSITY OF ARIZONA · PI KUNIHIRO, ANDREW GEORGE KENRO · 2018 to 2019
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Comparative Effects of Turmeric Secondary Metabolites Across Resorptive Bone Diseases. · full record | OpenQuestion